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Infection with Trypanosoma cruzi induces inflamma-
tion, which limits parasite proliferation but may re-
sult in chagasic heart disease. Suppressor of cytokine
signaling 2 (SOCS2) is a regulator of immune re-
sponses and may therefore participate in the patho-
genesis of T. cruzi infection. SOCS2 is expressed dur-
ing T. cruzi infection, and its expression is partially
reduced in infected 5-lipoxygenase–deficient [knock-
out (KO)] mice. In SOCS2 KO mice, there was a reduc-
tion in both parasitemia and the expression of inter-
feron- (IFN-), tumor necrosis factor- (TNF-), IL-6,
IL-10, SOCS1, and SOCS3 in the spleen. Expression of
IFN-, TNF-, SOCS1, and SOCS3 was also reduced in
the hearts of infected SOCS2 KO mice. There was an
increase in the generation and expansion of T regu-
latory (Treg) cells and a decrease in the number of
130memory cells in T. cruzi–infected SOCS2 KO mice.
Levels of lipoxinA4 (LXA4) increased in these mice.
Echocardiography studies demonstrated an impair-
ment of cardiac function in T. cruzi–infected SOCS2
KO mice. There were also changes in calcium han-
dling and in action potential waveforms, and reduced
outward potassium currents in isolated cardiac myo-
cytes. Our data suggest that reductions of inflamma-
tion and parasitemia in infected SOCS2-deficient mice
may be secondary to the increases in Treg cells and
LXA4 levels. This occurs at the cost of greater infec-
tion-associated heart dysfunction, highlighting the
relevance of balanced inflammatory and immune
responses in preventing severe T. cruzi–induced
disease. (Am J Pathol 2012, 181:130–140; http://dx.doi.org/
10.1016/j.ajpath.2012.03.042)
Chagas disease is caused by infection with the proto-
zoan parasite Trypanosoma cruzi. This infection results in
acute myocarditis and chronic cardiomyopathy. Cha-
gasic cardiomyopathy is the result of intense multifocal
progressive inflammation of the myocardium1 and dam-
age to the vascular endothelium2–4 resulting in vaso-
spasm and reduction in blood flow.5 Chronic chagasic
heart disease may manifest insidiously as congestive
heart failure or abruptly with arrhythmias, conduction ab-
normalities, and/or thromboembolic events. Dilated con-
gestive cardiomyopathy is an important manifestation
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infection.6 Pathological examination of the heart reveals
chronic inflammation and fibrosis. Electrocardiography,
echocardiography, and cardiac magnetic resonance im-
aging are useful in assessing the severity of disease in
experimental animals and humans.6
Protective immunity against T. cruzi is characterized by
a T helper type 1 (TH1)-type response where the cyto-
kines interferon- (IFN-), tumor necrosis factor- (TNF-
), and IL-12 contribute to the control of parasite replica-
tion.7–9 Early in infection, several T. cruzi–derived
molecules, including glycosylphosphatidylinositol mu-
cins and parasite DNA10,11 stimulate the synthesis of
IL-12 and TNF- by macrophages.12 Once secreted in
vivo, IL-12 induces natural killer (NK) cells to synthesize
IFN-, which in turn induces increased levels of IL-12 that
cycles back to enhance IFN- production by NK cells.
IFN- production is also amplified by IFN-–induced pro-
duction of macrophage TNF- and IL-1 by a positive
feedback loop. Importantly, these cytokines drive the
generation of type 1 CD4 and CD8 T cells, which
produce further IFN-, a key requirement for inducing
and maintaining control of acute infection.13 The down-
regulatory cytokines IL-10 and transforming growth fac-
tor- (TGF-) are associated with susceptibility to infec-
tion13,14 by inhibiting IFN-–mediated macrophage
activation. Resistance to the initial infection is a result of a
balance between proinflammatory IFN- and anti-inflam-
matory IL-10 production.13 The immune response gener-
ated to T. cruzi is largely effective at controlling, but not
eliminating, the infection, which is life-long unless treat-
ment is provided.
Suppressor of cytokine signaling 2 (SOCS2) is known
to have important actions in the regulation of various
cytokine/growth hormone-mediated processes, including
somatic growth, metabolism, and response to infec-
tion.15,16 Among the SOCS family, SOCS2 may regulate
the expression of other members, including SOCS1 and
SOCS3,15,17 effects that may eventually result in en-
hanced function of certain cytokines. Importantly, SOCS2
is known to regulate the cytokine-dependent Janus ki-
nase (JAK)/signal transducers and activators of tran-
scription (STAT) signaling pathway in cells of the innate
and adaptive immune systems, modulating the produc-
tion of several mediators, including TNF- and IL-
12,15,16,18 and favoring T helper 2 (Th2) differentiation
and production of Th2 cytokines.18 SOCS2 is involved in
the regulation of immune response in T. gondii infec-
tion.16,19 Because SOCS2 plays a role in certain infec-
tions and has been shown to modulate cytokines that are
crucial for the pathogenesis of T. cruzi infection, we con-
ducted studies to evaluate the expression and potential
role(s) of SOCS2 in the pathogenesis of T. cruzi–induced
heart disease. We present evidence for a role for SOCS2
in the modulation of experimental T. cruzi infection and
suggest how it may interfere with cardiac function. These
data provide a new insight into the pathogenesis of cha-
gasic heart disease as well as provide novel therapeutic
targets to ameliorate disease progression.Materials and Methods
Mice
Wild-type (WT) C57BL/6 mice were obtained from CEBIO
[Centro de Bioterismo–Universidade Federal de Minas
Gerais (UFMG)]. 5-Lipoxygenase (5-LO) KO (129-
Alox5tm1Fun/J; as described by Chen et al20) and SOCS2
KO (as described by Metcalf et al21) mice were kindly
provided by Dr. Fernando Queiroz Cunha (University of
Sao Paulo, Ribeirao Preto, Brazil) and Dr. Warren S. Al-
exander (the Walter and Eliza Hall Institute of Medical
Research, Australia), respectively. 5-LO KO strain–
matched WT mice were kindly provided by Dr. Vanessa
Pinho da Silva (Federal University of Minas Gerais). All
animal lineages were bred and maintained under patho-
gen-free conditions at the Institute of Biological Science-
s–UFMG animal facility. All animal experiments were ap-
proved by the local animal ethics committee.
Parasites and Experimental Infection
The Y strain of T. cruzi was maintained in C57BL/6 mice.
Seven- to 8-week-old WT and KO mice were infected
intraperitoneally with 1  103 trypomastigotes, and par-
asitemia determined daily in 5 L of blood collected from
a tail vein.22 For in vitro infection, trypomastigotes were
grown and purified from a monkey kidney epithelial cell
line (LLC-MK2).
Macrophage Culture, Evaluation of NO2

Production, and Microbicidal Activity
WT and SOCS2 KO inflammatory macrophages were har-
vested from peritoneal cavities 3 days after injection of 1 mL
of 3% sodium thioglycollate. The cells were washed and
cultured (1  106 cells/mL) in RPMI 1640 (Sigma-Aldrich,
St. Louis, MO), supplemented with 5% fetal bovine serum,
50 mol/L 2-mercaptoethanol, 2 mmol/L L-glutamine, and
penicillin/streptomycin (all from GIBCO, Grand Island, NY).
The adherent cells were obtained after 2 to 4 hours of
incubation of single-cell suspensions in tissue culture plates
at 37°C in 5% CO2. Nonadherent cells were removed, and
trypomastigote forms were added at a 5:1 parasite-to-cell
(macrophage) ratio for 3 hours, after which the extracellular
parasites were removed, and the cells were incubated at
37°C in 5% CO2 in the presence or absence of 100 ng/mL
of recombinant murine IFN- (GIBCO). The supernatants
were harvested 24, 48, and 72 hours post infection and
assayed for nitrite concentration by mixing 0.1 mL of culture
supernatant with 0.1 mL of Griess reagent. Absorbance at
540 nm was read 10 minutes later, and NO2
 concentration
was determined. Macrophages were infected, the extracel-
lular parasites were removed, and the cells were incubated
with or without IFN- as described above. Parasite growth
was evaluated by daily counting of the trypomastigotes in
the supernatant of infected macrophages on days 3 to 7
post infection. The intracellular amastigote growth rate was
evaluated in macrophages plated (5  105 cell/mL) onto
chamber slides (Nalge Nunc, Naperville, IL), as de-
scribed.8,22
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Left ventricular cardiac myocytes from age-matched mice
were enzymatically isolated as previously described, with
minor modifications.23 Hearts were quickly removed,
mounted, and then perfused using a customized Langen-
dorff apparatus for 5 minutes with nominally Ca2-free so-
lution containing 130 mmol/L NaCl, 5.4 mmol/L KCl, 0.5
mmol/L MgCl2, 0.33 mmol/L NaH2PO4, 3 mmol/L pyruvate,
22 mmol/L glucose, and 25 mmol/L HEPES (pH 7.4). Hearts
were then perfused for 10 to 15 minutes at 37°C with a
solution containing 1 mg/mL type II collagenase (Worthing-
ton Biochemical Corporation, Lakewood, NJ). The digested
heart was removed from the cannula, and the left and/or
right ventricular free wall was separated, gently agitated,
centrifuged (180 g, 10 seconds at room temperature) and
stored in Dulbecco’s modified Eagle’s medium (Sigma-Al-
drich). The isolated cardiac myocytes were stored at room
temperature and used within 4 to 6 hours of isolation. Only
calcium-tolerant, quiescent, rod-shaped myocytes showing
clear cross striations were studied.
Whole-Cell Ruptured, Patch Clamp Technique
Whole-cell voltage and current-clamp recordings were
obtained using an EPC-9.2 patch clamp amplifier (HEKA
Electronics, Lambrecht/Pfalz, Germany).24 On attaining
the whole-cell configuration, the cells were equilibrated
for 3 to 5 minutes in the pipette solution. The experiments
were carried out at room temperature (24°C to 27°C). The
recording electrodes had resistances of 0.5 to 1.5 M.
Current recordings were low-pass filtered (2.9 kHz) and
digitized at 10 kHz before being stored on a computer.
Myocytes showing series resistance (Rs) larger than 7 M
were not used in the analysis. Rs compensation was used at
40% to 70%. We used Tyrode’s as a bath solution of 140
mmol/L NaCl, 5.4 mmol/L KCl, 1 mmol/L MgCl2, 1.8 mmol/L
CaCl2, 10 mmol/L glucose, 10 mmol/L HEPES (pH 7.4). For
measurements of ICa,L, recording pipettes were filled with
internal solution containing 120 mmol/L CsCl, 20 mmol/L
TEACl, 5 mmol/L NaCl, 10 mmol/L HEPES, 5 mmol/L EGTA,
pH set to 7.2 with CsOH. ICa,Lwas recorded in the presence
of 1.8 mmol/L extracellular Ca2. Membrane potential was
first stepped from a holding potential of80 mV to40 mV
for 50 ms (to inactivate Na channels), and then stepped to
different membrane voltages between 40 to 50 mV
(300-ms duration). To measure action potentials (AP) and
outward potassium current (Ito), pipette solution contained
130 mmol/L potassium aspartate, 20 mmol/L KCl, 10
mmol/L HEPES, 2 mmol/L MgCl2, 5 mmol/L NaCl, 5 mmol/L
EGTA, pH set to 7.2 with KOH. With regular Tyrode’s as a
bath solution, we recorded 30 to 50 AP per cell (at 1 Hz),
until a stable recording condition was achieved, and we
used the last recorded AP to perform the complete analysis.
Ito was elicited by depolarization steps from 40 to 70 mV
(3-seconds duration) from a holding potential of 80 mV at
a stimulation frequency of 0.066 Hz. We used a 50-ms
pre-pulse to 40 mV from 80 mV to inactivate INa but still
be able to record Ito.
24
Current-density relationships were fitted using the fol-
lowing equation:IVGmax *
(Vm Ei)
1 exp(Vm V0.5)  S
(1)
where Gmax is the maximal conductance; Vm is the test
membrane potential; Ei, electrochemical equilibrium poten-
tial for ion i; V0.5 is the membrane potential where 50% of the
channels are activated; and S is the slope factor.23,24
Echocardiography
Echocardiography (Visual Sonics, Toronto, ON, Canada)
was performed on mice anesthetized with 1.5% isoflu-
rane. Heart morphology was assessed using M-mode
configuration. Cardiac output and ejection fraction were
obtained from the B-mode according to Simpson’s
method. All parameters were evaluated following proto-
cols of the American Society of Echocardiography.25
Transient Ca2 Recordings
Adult ventricular myocytes were isolated as described
above, and intracellular Ca2 (Ca2i) imaging experiments
were performed as described26 with cardiac myocytes
loaded with Fluo-4 AM (10 mol/L; Invitrogen, Eugene,
OR) for 25 minutes. Cells were electrically stimulated at 1
Hz to produce steady-state conditions. The confocal line-
scan imaging was performed with a Zeiss LSM 510META
confocal microscope (Carl Zeiss, Oberkochen, Germany)
(Centro de Microscopia Eletronica, UFMG). Digital im-
age processing was performed by using custom-de-
vised routines created with the IDL programming lan-
guage (Research Systems, Boulder, CO). The Ca2
level was reported as F/F0, where F0 is the resting Ca
2
fluorescence.
LipoxinA4 and Cytokine Determinations
The concentration of LipoxinA4(LXA4) was measured us-
ing commercially available antibodies and according to
the procedures supplied by the manufacturer (Neogen,
Lexington, KY). IL-12 p40 and IFN- levels were mea-
sured using commercial ELISA kits (BD Biosciences/
Pharmingen, San Jose, CA, and R&D Systems, Minneap-
olis, MN, respectively). For in vivo experiments, a
minimum of five mice were infected as described above,
and on different days post infection were bled for assess-
ment of cytokine levels in the serum.
Total RNA Extraction and cDNA Preparation by
Reverse Transcription
Total RNA was isolated from mouse cardiac and splenic
tissue, homogenized in 1 mL of Brazol reagent (LGC
Biotecnologia, Cotia, Brazil) according to the manufac-
turer’s instructions, followed by the addition of 0.2 mL of
chloroform (Sigma-Aldrich). Purified RNA (2 g) was
used to synthesize cDNA using Superscript II (GIBCO).
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Detection
The expression of mRNA for cytokines (IL-6, IL-10, IL-12,
TNF-, and IFN-), SOCS1, SOCS2, SOCS3, and -actin
was analyzed by RT-PCR, with GoTaqGreen Master Mix
(Promega, Madison, WI) in a PTC-100 thermal cycler (MJ
Research, Alameda, CA). The reaction conditions were
34 cycles of 1 minute at 94°C, 1 minute at 60°C, and 1
minute at 72°C, with a final extension step of 2 minutes at
72°C. The parasite load was detected using a T. cruzi–
specific primer (rDNA 24S ). Reaction conditions were
30 cycles of 1 minute at 94°C, 1 minute at 60°C, and 1
minute at 72°C, with a final extension step of 10 minutes
at 72°C. PCR products were separated by agarose gel
electrophoresis and stained with ethidium bromide. The
primer sequences and PCR products for cytokines and
-actin have been described before.16 The primer se-
quences for T. cruzi load were (forward: 5=-AAGGT-
GCGTCGACAGTGTGG-3= and reverse: 5=-TTTTCA-
GAATGGCCGAACAGT-3=), 125 bp.
Spleen Cell Cultures
Suspensions of splenocytes from uninfected and chron-
ically T. cruzi–infected mice (6 months post infection)
were washed in Hanks’ balanced salt solution and
treated with lysis buffer [nine parts 0.16 mmol/L ammo-
nium chloride and one part 0.17 mmol/L Tris-HCl (pH
7.5)] for 4 minutes. The erythrocyte-free cells were then
washed three times in Hanks’ balanced salt solution and
adjusted to cells per mL of RPMI 1640 (Sigma-Aldrich)
supplemented with 10% fetal calf serum (Cultilab, Campi-
nas, Brazil), 2-mercaptoethanol (Invitrogen), L-glutamine
(GIBCO), and penicillin/streptomycin (all from GIBCO).
The cell suspension was cultured in 24-well tissue-culture
plates (1 mL/well; Nalge Nunc) for 48 hours at 37°C, 5%
CO2 atmosphere, either in the presence or absence of
trypomastigotes (five parasites per cell) or T. cruzi antigen
(10 g/mL). The supernatants were harvested, and IFN-
levels were measured using commercial enzyme-linked
immunosorbent assay (ELISA) kits (R&D Systems).
Flow Cytometry Analysis
Splenocytes were purified from the T. cruzi–infected mice
[0, 8, 15, 29, or 180 days post infection (dpi)] as de-
scribed above. Splenocytes purified from 0 and 15 dpi
were plated and incubated with brefeldin A (1 g/mL)
(Invitrogen). Four hours post treatment, the cells were
fixed and stained with labeled antibodies against IFN-
(fluorescein isothiocyanate), CD4 (phycoerythrin), or CD8
(peridinin chlorophyll protein complex) (BD Biosciences/
Pharmingen). Cells harvested from spleen and thymus 0,
8, 15, and 29 days post infection were directly stained
with the combination of CD4 (peridinin chlorophyll protein
complex), CD25 (phycoerythrin), and FOXP3 (fluorescein
isothiocyanate) specific antibodies. Viable cells were an-
alyzed by flow cytometry using FlowJo software version
8.7 (Tree Star, Ashland, OR).Heart Histopathology, Morphometric Analysis,
and Parasitism
To compare the effects of SOCS2 expression on the influx
of inflammatory cells in the heart, we analyzed the pattern
and intensity of myocarditis by morphometry. For this
experiment, the hearts from three mice from each group
were removed at 15 days post infection and cut transver-
sally. Each heart was washed in phosphate-buffered sa-
line and fixed in 4% phosphate-buffered formaldehyde.
After 24 hours of fixation, the tissues were paraffin-em-
bedded, and three 5-m-thick, semiconsecutive sections
were stained by H&E for inflammation assessment or by
Trichrome to evaluate fibrosis. Inflammation and fibrosis
were assessed both in the atrial and ventricular free walls
and in the interventricular septum, in five fields from each
H&E- or Trichrome-stained section randomly chosen at a
20 objective magnification, analyzing a myocardial
area of 1.5 106 m2 per field. Images were captured at
a resolution of 1392  1040 pixels with a CoolSNAP-Pro
cf color microcamera (Media Cybernetics, Bethesda,
MD) and analyzed in Image-Pro Express, version 4.0
(Media Cybernetics) and KS300 software (Carl Zeiss,
Jena, Germany). An automatic macro recorder assem-
bler (an algorithm of the KS300 software) was elaborated
for capture, image processing, and segmentation, defi-
nition of morphometry conditions and counts of all of the
cells detected in each image. The nucleus from each cell
presented in the analyzed fields were counted and ex-
pressed as cells per field. Fibrosis was assessed using the
image segmentation function. All pixels with blue hues in the
Trichrome sections were selected to build a binary image
and subsequently to calculate the total area occupied by
connective tissue per field (fibrosis area per field). Heart
parasitism was qualitatively evaluated by counting the num-
ber of parasite nests in three semiconsecutive sections as
visualized by light microscopy with an 40 objective.
Statistical Analysis
The statistical significance of differences in mean values
between experimental versus control or vehicle-treated
samples was evaluated by Student’s t-test, one-way analy-
sis of variance, or two-way analysis of variance. Bonferroni
corrections were used as needed for multiple comparisons.
Differences were considered to be significant at P  0.05.
Results
Expression of SOCS2 in Infected Mice Is
Partially 5-LO Dependent
5-LO activation and eicosanoid production, mainly LXA4,
may be involved in the modulation of SOCS2 expression.
SOCS2 expression was increased in the spleen and car-
diac tissue of T. cruzi–infected WT mice (Figure 1, A and
B). There was a partial reduction in the expression of
SOCS2 in both organs of 5-LO KO mice, indicating that
products of this enzyme contribute to SOCS2 expression.
CS2 ver
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Tissue Parasitism, andMacrophage Function During
T. cruzi Infection in Mice
Parasitemia was significantly reduced in SOCS2 KOmice
compared with WT mice (Figure 1C). There was no sig-
nificant difference in parasite load in the heart WT and
SOCS2 KO mice (Figure 1D). Macrophages obtained
from SOCS2 KO mice were hyperresponsive to IFN-
stimulation, producing higher levels of NO (Figure 1, E
and F) and increased parasite killing compared with WT
macrophages (Figure 1, G and H). However, nonstimu-
lated SOCS2 infected macrophages were more suscep-
tible to infection than WT cells (Figure 1H).
Inflammatory Cytokine Responses, Expansion of T
Regulatory andMemory Cells Are Controlled by a
Regulatory Pathway Dependent on SOCS2 in Vivo
We evaluated the immune response to T. cruzi in SOCS2
KO mice. There was significantly decreased expression
of IL-6, TNF-, IL-12, IFN-, and IL-10 in the spleen (Fig-
ure 2A) and of TNF- and IFN- in the heart (Figure 2B) of
T. cruzi–infected SOCS2 KO mice when compared to
those of infected WT mice. Infection of SOCS2 KO mice
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post infection in SOCS2 KO mice (Figure 3A). The num-
ber of TH1 IFN-–producing CD4
 as well CD8 T cells
was reduced in infected SOCS2 KO mice (Figure 3B).
To investigate the basis for these observations, we
determined both LXA4 production and the generation/
expansion of Treg during T. cruzi infection. There was an
increase in LXA4 in the spleen (Figure 3C) and increased
numbers of Treg cells in the thymus and spleen of T.
cruzi–infected SOCS2 KO mice when compared with WT
infected counterparts (Figure 3D). TGF- levels were in-
creased and IL-10 levels decreased in spleen of infected
SOCS2 KO mice compared with WT mice (data not
shown). Additionally, SOCS2 deficiency resulted in a re-
duction in the generation of memory T cells specific for T.
cruzi. SOCS2-deficient lymphocytes harvested from
chronically infected mice produced reduced levels of
IFN- during recall responses in vitro when compared
with WT infected mice (Figure 3E).
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AJP July 2012, Vol. 181, No. 1was intense lymphocytic myocarditis and deposition of
collagen in the myocardium of WT mice 15 days post
infection (Figure 4). By contrast, there was only mild
myocarditis and few nests of inflammatory cells in in-
fected SOCS2 KO mice (Figure 4). However, no differ-
ence in the number of parasite nests was found between
WT and SOCS2 KO mice (data not shown).
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prompted the examination of these mice for any evi-
dence of myocardial dysfunction. Echocardiography
performed 15 days post infection demonstrated no sig-
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Figure 4. The myocardial pathology was examined in infected WT and
SOCS2 KO mice 15 days post infection. Sections of cardiac tissue from WT
(A,C, and E) and SOCS2 KO (B,D, and F) mice were either uninfected (A and
B) or infected (C–F) with 103 trypomastigotes, fixed, and then stained with
H&E and Gomori’s Trichrome. Thin arrows indicate tissue inflammatory
infiltrate (C and D), and thick arrows indicate the site of fibrosis (E and F)
in the tissue. The inflammatory score (G) and the cardiac fibrosis (H) are
shown. *P 0.001 for SOCS2 versus WT mice infected with T. cruzi. Original
magnification: 4 (A and B); 10 (C and D); 20 (E and F); 40 (C–F
insets). The myocardial inflammation was reduced in infected SOCS2 KO
mice compared to infected WT mice. Data are shown as the means SD and
are representative of two independent experiments. *P  0.05 for SOCS2
versus WT mice infected with T. cruzi.nificant differences in right ventricular area or ejectionfraction (Figure 5, A and B) in infected WT or SOCS2
KO mice compared with uninfected mice. Infected
SOCS2 KO mice displayed cardiac hypertrophy as
determined by higher fraction of circumferential area
and increased left ventricular mass when compared
with WT animals (Figure 5, C and D).
Patch clamping and confocal microscopy were used
to evaluate cardiac myocyte physiology because
changes in electrophysiological properties and calcium
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Figure 5. Evaluation of cardiac hypertrophy in infected SOCS2 KO mice.
Cardiac function of WT and SOCS2 KO mice infected with 1000 trypomas-
tigotes of T. cruzi as assessed by echocardiography. A: Right ventricular (RV)
area, ejection fraction (EF) (B), fraction of circumferential area (FAC) (C), and
left ventricular hypertrophy computed from LV mass (mg)/LV (D) area
(mm2). *P  0.05 versus WT uninfected, †P  0.05 versus WT infected, and
‡P  0.05 versus SOCS2 KO uninfected. Infected SOCS2 KO mice displayed
cardiac hypertrophy as determined by higher FAC and increased LV mass
when compared with WT animals (C and D). CT, control.
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AJP July 2012, Vol. 181, No. 1handling are a major cause of heart failure.24,27 Reduced
L-type calcium and outward potassium currents in
SOCS2 deficient cardiac myocytes were observed 15
days post infection compared to infected WT mice (Fig-
ure 6, A–D). However, in uninfected WT and SOCS2 KO
mice, L-type calcium and outward potassium currents,
and action potential repolarization were almost identical.
Furthermore, infected SOCS2 KO mice displayed an in-
creased time to action potential repolarization when com-
pared with WT mice (Figure 6, E and F). Typical line-scan
fluorescence images recorded from electrically stimu-
lated Fluo-4 AM–loaded ventricular myocytes are shown
in Figure 7, A and B. T. cruzi infection led to a significant
Figure 6. The consequence of the absence of SOCS2 alters the electrophysio
L-type calcium current (ICa,L) recordings from WT CT, WT 15 dpi, SOCS2 K
(pA/pF) from 40 to 50 mV for WT CT, WT 15 dpi, SOCS2 KO CT, SOCS2
from WT CT, WT 15 dpi, SOCS2 KO CT, SOCS2 KO 15 dpi. D: Voltage depe
15, SOCS2 KO CT, SOCS2 KO 15 dpi). E: Representative action potential (AP)
AP repolarization time at different repolarization levels. n  number of cells.
§P  0.05 SOCS2 KO 15 dpi versus WT 15 dpi. D: *P  0.05 WT 15 dpi and S
increased in SOCS2 infected mice. *P  0.05 versus WT uninfected; †P  0.
days post infection.
A
WT CT WT 15dpi SOCS2 KO CT SO
1 sec
Bincrease in the amplitude of the calcium transient in car-
diac myocytes isolated 15 days after infection (Figure 7)
(peak Ca2 F/F0, WT control: 3.362  0.091, n  84
isolated cells; WT infected: 3.986  0.133, n  82 iso-
lated cells; P  0.001). There was no difference in the
kinetics of decay of the calcium transient (T50, ms) after
infection of cardiac myocytes (Figure 7) (WT control:
266.1  5.879, n  84 isolated cells; WT infected:
261.4  6.695, n  82 isolated cells). In SOCS2-deficient
cardiac myocytes, there was an increase in calcium tran-
sient after infection that was only slightly smaller than in
infected WT mice (Figure 7) (peak Ca2 F/F0, WT in-
fected: 3.986  0.133, n  82 isolated cells; and SOCS2
haracteristics of cardiac myocytes during T. cruzi infection. A: Representative
CS2 KO 15 dpi. B: Voltage dependence of ICa,L, plotted as current density
dpi). C: Representative transient outward potassium current (Ito) recordings
of Ito, plotted as current density (pA/pF) from 40 to 70 mV for WT CT, WT
T CT, WT 15 dpi, SOCS2 KO CT, SOCS2 KO 15 dpi. F: Bar graphs comparing
0.05 SOCS2 KO 15 dpi and WT 15 dpi versus WT and SOCS2 KO uninfected;
5 dpi versus WT and SOCS2 KO uninfected. F: Parameters were significantly
s WT 15 dpi; and ¶P  0.05 versus SOCS2 KO uninfected. CT, control; dpi,
O 15dpi
Figure 7. T. cruzi infection alters calcium handling in ven-
tricular myocytes from SOCS2 KO mice. The T. cruzi infec-
tion increased the peak Ca2 transient amplitude in cardio-
myocytes obtained from WT and SOCS2 KO mice, but
changed the decay kinetics of only the infected SOCS2 KO
mice. A: Representative confocal images of electrically stim-
ulated intracellular Ca2 transient recordings in ventricular
myocytes. B: Representative Ca2 transient line-scan profile.
CT, uninfected mice; dpi, days post infection.logical c
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AJP July 2012, Vol. 181, No. 1KO infected: 3.835  0.154, n  54 isolated cells). In
addition, the kinetics of decay of the calcium transient
after infection of cardiac myocytes was slower in infected
SOCS2-deficient cardiac myocytes than infected WT
(Figure 7) (WT infected: 261.4  6.695, n  82 isolated
cells; and SOCS2 KO infected: 294.9  7.509, n  54
isolated cells; P  0.05).
Discussion
We have described, for the first time, the role of SOCS2 in
the pathogenesis of an experimental model of Chagas
disease. Our results can be summarized as follows: i) T.
cruzi infection induced SOCS2 expression in the heart of
mice that was, in part, dependent on the activation of the
5-LO pathway; ii) SOCS2 deficiency resulted in reduction
in peripheral parasitemia, but not in heart parasitism, and
in the down-modulation of proinflammatory cytokines, in-
cluding TNF-, IL-12, and IFN-, and reduced myocar-
dial inflammation; iii) although IFN- was reduced,
SOCS2-deficient macrophages were hyperresponsive to
this cytokine and dealt with infection more efficiently; iv)
mechanistically, enhanced number of Treg cells and en-
hanced levels of LXA4 were associated with decreased
inflammatory responses and reduced production of pro-
inflammatory mediators; and v) in the absence of SOCS2,
there was myocardial (hypertrophy) and cardiac myocyte
(altered calcium handling) dysfunction. Altogether, these
results clearly show that SOCS2 expression facilitates
inflammatory and immune responses in T. cruzi–infected
mice at the cost of preventing myocardial dysfunction.
Initial experiments demonstrated that SOCS2 expres-
sion induced by T. cruzi infection was partially dependent
on the 5-LO pathway. This pathway has received atten-
tion in the field of inflammation research because of the
association of infection and leukotriene B (LTB) synthe-
sis. LTBs have been reported to be important in the
control of infection by protozoan parasites.28,29 In addi-
tion to LTBs, 5-LO induces LXA4 production that triggers
the AhR receptor altering the expression of SOCS2.16
These results suggest that production of a 5-LO–derived
molecule, presumably LXA4, contributes to SOCS2 ex-
pression during experimental T. cruzi infection. It is inter-
esting to notice that the phenotype of 5-LO–deficient
mice infected with T. cruzi30 is similar to those observed
here. Indeed, absence of 5-LO was associated with de-
creased inflammatory infiltrate and production of proin-
flammatory cytokines,30 suggesting that in addition to
absence of LTB, decreased expression of SOCS2 could
account for the phenotype observed in 5-LO–deficient
mice. Since there was still increased SOCS2 expression
in the absence of 5-LO, our results also suggest that
other pathways may be involved in SOCS2 expression on
infection.
SOCS2 deficiency resulted in a reduction in peripheral
parasitemia, but not in heart parasitism, even in presence
of reduced expression of IFN-. The in vitro observations
suggest that resistance to infection (parasite replication)
could be attributable to an increased ability of SOCS2-
deficient macrophages stimulated with IFN- to kill intra-cellular amastigotes via increased production of NO. We
found that SOCS2-deficient macrophages were hyperre-
sponsive to IFN- stimulation, which could be attributed to
reduced inhibition of IFN- receptor signaling. Interestingly,
T. cruzi–infected SOCS2 KOmacrophages that are not stim-
ulated with cytokines release greater numbers of trypomas-
tigotes in the culture supernatants compared with WT cells
despite producing a similar concentration of NO. Further
studies are required to understand the molecular mecha-
nisms underlying these observations.
Absence of SOCS2 was clearly associated with de-
creased levels of cytokines in spleen and heart of T.
cruzi–infected mice and decreased inflammatory infil-
trate. This was at first a unexpected finding, because
SOCS2 is known to suppress the function of cytokines.
Hence, absence of SOCS2 would presumably be asso-
ciated with enhanced cytokine responses. However, two
observations help to explain our results. In the absence of
SOCS2, there were greater numbers of Treg cells and
enhanced production of LXA4.
The role of Treg in experimental T. cruzi infection is still
somewhat controversial.31 Part of this controversy stems
from the difficulty in depleting specifically Treg cells in
vivo and in differences of experimental models used.
However, CD4CD25 cells expressing FoxP3 have
been shown to associate with better outcome in chagasic
patients.32 Moreover, an increased frequency of Treg
cells was found during the acute phase of experimental
T. cruzi infection in mice.31 In mice, there is also evidence
to show that Treg cells migrate to the heart of infected
mice and may have a protective role.33 Taken together,
these studies suggest that Treg cells likely control dis-
ease severity during T. cruzi infection. Therefore, the en-
hanced numbers of Treg cells in SOCS2 KO mice may
explain the reduced tissue inflammation observed in these
mice. Production of anti-inflammatory cytokines, including
IL-10 and TGF-, account for most of the immunosuppres-
sive effects of Treg cells in various experimental systems.34
In our model, SOCS2 was not associated with increased
production of IL-10, but with enhanced expression of
TGF-, suggesting the latter is the major pathway by which
Treg cells may alter immune function in SOCS2-deficient
mice. It is not clear why absence of SOCS2 would result in
greater numbers of Treg cells after T. cruzi infection. AhR, a
lipoxin receptor that may trigger SOCS2 expression, modi-
fies Treg balance by modifying the cytokine milieu.35 There-
fore, we are currently investigating the possibility of induc-
tion of SOCS2 expression by activation of AhR receptor
during T. cruzi infection as a modulator of Treg generation
and expansion.
There was an increase in levels of LXA4 in SOCS2 KO
mice after T. cruzi infection. Because LXA4 is an effective
anti-inflammatory molecule,36,37 enhanced levels of this
lipid could account, at least partially, for the reduced
inflammation and production of proinflammatory cyto-
kines. It must be noted that LXA4 may function in SOCS2-
dependent and -independent manners. As the lipid was
enhanced in the absence of SOCS2, it is clear that
SOCS2-independent pathways could be operational in
the latter animals to mediate any anti-inflammatory ac-
tions of LXA4.
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AJP July 2012, Vol. 181, No. 1Severe chronic Chagas heart disease is characterized
by dilation of chambers, decreased ejection fraction, and
electrical instability.6 In our system, evaluation of heart
function in WT mice at 15 days after infection was not
associated with any major changes in heart function.
Only when experiments were conducted in SOCS2-defi-
cient mice did we notice that LV mass was increased and
the fraction of circumferential area enhanced, suggesting
that there were compensatory mechanisms operating at
this early stage in these mice to prevent dysfunction.
Overall, these data are indicative that SOCS2 deficient
mice are more likely to develop heart dysfunction on
infection. Electrophysiological studies showed that infec-
tion caused reduction of the outward potassium current
and in L-type calcium current amplitude. These changes
were more marked in the absence of SOCS2 and the
calcium transient was also prolonged. Altogether, these
changes in SOCS2-deficient mice could lead to greater
duration of the action potential that could provide an
electrophysiological basis for the echocardiographic
findings. It has been demonstrated that different cyto-
kines can modulate ionic currents in isolated cardiac
myocytes.38,39 A correlation between reduced cardiac
myocyte shortening and increased levels of TNF- and
IFN- during T. cruzi infection has been previously dem-
onstrated.23 It is still unclear how the profile of cytokines
found in the absence of SOCS2 correlates with the al-
tered cardiac myocyte electrical remodeling. However,
results showing decreased expression of SOCS1 and
SOCS3 may provide an explanation to our findings.
SOCS1 and SOCS3 expression is known to counteract
the actions of molecules, such as IL-6, which induce
cardiac myocyte hypertrophy.40 For example, leukemia
inhibitory factor (LIF), a member of the IL-6 family, has
been reported to increased ICa,L thought activation of
ERK, a pathway known to be blocked by SOCS.41 Be-
cause there was reduced SOCS1 and SOCS3 in SOCS2-
deficient mice, one would expect greater ability of the
inflammatory milieu found in the infected heart to induce
more hypertrophy. However, the mediators of this hyper-
trophic response still need to be identified.
In summary, this report demonstrates the importance
of SOCS2 in the modulation of experimental T. cruzi in-
fection. In the absence of SOCS2, there is decreased
inflammation and parasitemia, which are associated with
an increase in the number of Treg cells and the LXA4
levels. This occurs at the cost of greater infection-asso-
ciated heart dysfunction. Therefore, the expression of
SOCS2 during T. cruzi infection decreases heart dysfunc-
tion at the cost of greater parasitemia and tissue inflam-
mation. These studies highlight the role of SOCS2 in
balancing immune and physiological functions in the
heart of animals subjected to an infections insult.
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